(GT)(n) Repeat Polymorphism in Heme Oxygenase-1 (HO-1) Correlates with Clinical Outcome after Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation

Allogeneic hematopoietic cell transplantation (HCT) is a treatment for various hematologic diseases where efficacy of treatment is in part based on the graft versus tumour (GVT) activity of cells in the transplant. The cytoprotective enzyme heme oxygenase-1 (HO-1) is a rate-limiting enzyme in heme d...

Descripción completa

Detalles Bibliográficos
Autores principales: Køllgaard, Tania, Kornblit, Brian, Petersen, Jesper, Klausen, Tobias Wirenfeldt, Mortensen, Bo Kok, Brændstrup, Peter, Sengeløv, Henrik, Høgdall, Estrid, Müller, Klaus, Vindeløv, Lars, Andersen, Mads Hald, thor Straten, Per
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5172582/
https://www.ncbi.nlm.nih.gov/pubmed/27997582
http://dx.doi.org/10.1371/journal.pone.0168210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5172582/
https://www.ncbi.nlm.nih.gov/pubmed/27997582
http://dx.doi.org/10.1371/journal.pone.0168210

Ejemplares similares